Navigation Links
GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013

GAITHERSBURG, Md., March 15, 2013 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the fourth quarter and year ended December 31, 2012 on Friday, March 22, 2013, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the company's fourth quarter and 2012 financial results and 2013 business outlook.

To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980 (international) and use the following Conference ID: 17801867. An audio replay of the conference call will be available starting at 1:00 p.m. EDT on March 22, 2013 through March 29, 2013. To listen to the audio replay, dial 855-859-2056 or 404-537-3406 and use Conference Replay ID: 17801867.

To access the webcast or the replay, go to, click on "Investors and Media," and click on "Events and Presentations."

About GenVec
GenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD). Additional information about GenVec is available at and in the Company's various filings with the Securities and Exchange Commission.

Retail Investor and Media Contact:

GenVec, Inc.

Douglas J. Swirsky

(240) 632-5510

Institutional Investor Contact:

S.A. Noonan Communications

Susan A. Noonan

(212) 966-3650

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GenVec to Present at 25th Annual ROTH Conference
2. GenVec Reports Third Quarter 2012 Financial Results
3. GenVec Reports Second Quarter 2012 Financial Results
4. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
5. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
6. GenVec Reports Inducement Award
7. GenVec Appoints Cynthia Collins as President and CEO
8. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
9. GeneTex to Release New Antibodies for the Study of DNA Repair in Zebrafish
10. Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results
11. Ranbaxy to Market Desvenlafaxine Base Extended Release Tablets in the U.S.
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015 Research and Markets ... "Global Intrauterine Devices Market 2015-2019" report to ... --> In this report, the author the present ... market for 2015-2019. To calculate the market size, the ... type of products: Hormonal IUDs and copper IUDs. The ...
(Date:11/26/2015)... the Netherlands , November 26, 2015 ... A new combination approach blends immunotherapy with ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic ... the Netherlands has found that immunotherapy can ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Japanese therapeutic drug monitoring market, including emerging ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... November 29, 2015 , ... Doctors who missed a case of ... the signs of mesothelioma and push for a diagnosis, especially in people exposed to ... Click here to read it now. , Researchers at Gifu Prefectural Tajimi ...
(Date:11/28/2015)... California (PRWEB) , ... November 28, 2015 , ... ... image exchange technology and teleradiology services, has added Chris Hafey and Claude Hooton ... exhibit at the Radiological Society of North America (RSNA) 2015 Annual Meeting and ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back again with ... from, the possibilities are endless. Users have full control over angle of view, speed ... effects, users are sure to get heads to turn. , ProPanel: Pulse offers fully ...
(Date:11/27/2015)... ... , ... According to an article published November 15th by ABC ... security in light of the recent terrorist attacks in Paris, other cities are taking ... attack from reaching U.S. soil. Especially around special events that may be high-profile in ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
Breaking Medicine News(10 mins):